TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
RYTM

Rhythm Pharmaceuticals Inc

Healthcare · Biotechnology

92.80$ -0.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow RYTM
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.35 -0.38 -0.74 -0.68 -1.39 -1.10 -2.00 -3.37 -2.76 -2.94 -3.33 -2.36 -1.87 -1.78
0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.03 0.03 0.03 0.02
– 0.00 0.01 0.03 0.07 0.09 0.21 0.33 0.40 0.42 0.38 0.56 0.65 1.03
– – 0.01 0.17 0.07 0.15 0.21 0.33 0.39 0.41 0.39 – – –
0.00 0.04 -0.08 0.23 0.08 0.00 0.02 0.14 -0.13 0.04 -0.38 0.08 0.17 -0.01
0.00 0.00 0.00 0.00 0.06 0.00 0.02 0.09 0.00 0.11 0.08 0.00 0.00 0.01
-0.10 -0.10 0.00 0.00 -0.31 -4.12 -2.81 -0.77 3.59 -1.25 0.54 -0.10 -0.79 -2.11
– – – – – 0.00 – – – – – – 0.07 0.08
– – 0.73 4.09 7.55 6.26 5.31 4.49 0.05 3.36 2.71 – – –
– – – – – – – – – – 1.39 – – –
0.45 0.40 0.73 4.09 0.00 6.26 5.31 4.49 0.05 3.36 4.10 1.29 3.14 3.35
-0.01 -0.09 -0.01 3.40 -1.69 1.04 0.50 0.35 0.87 -0.84 1.31 -1.17 0.48 -0.54
-0.35 -0.38 -0.74 -0.69 -1.45 -1.11 -2.02 -3.46 -2.77 -3.05 -3.41 -2.36 -1.87 -1.79

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?